Intrabodies as antiviral agents.
Marasco
W A
WA
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Jimmy Fund Building, Room 824, Boston, MA 02115, USA.
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy; D000818:Animals; D000914:Antibodies, Viral / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D003593:Cytoplasm / Q000276:immunology / Q000821:virology; D004195:Disease Models, Animal; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors; D015483:HIV Antibodies / Q000627:therapeutic use; D015658:HIV Infections / Q000628:therapy; D015497:HIV-1 / Q000235:genetics / Q000276:immunology; D006801:Humans; D015202:Protein Engineering; D019713:Receptors, CCR5 / Q000235:genetics; D011995:Recombination, Genetic; D015301:Retroviruses, Simian / Q000235:genetics; D014162:Transfection; D014779:Virus Replication
D000914:Antibodies, Viral; D000998:Antiviral Agents; D015483:HIV Antibodies; D019713:Receptors, CCR5